Product Information
GABAPENTIN ER 300 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $1.0468 per EA under NDC 50228052390. Its NADAC has been published 25 times since Jan 7, 2026.
The High Outlier badge above means this manufacturer's average price in the gabapentin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228052390
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA218491On Market Since
9/20/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN ER 300 MG TABLET has been published 25 times since Jan 7, 2026, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0468 per EA |
|---|---|
| All-time high | $1.4921 (Feb 11, 2026) |
| All-time low | $1.0468 (Jun 17, 2026) |
| 52-week high | $1.4921 |
| 52-week low | $1.0468 |
| Median price | $1.4743 |
| Average price | $1.3905 |
| Largest weekly change | -13.7% (May 20, 2026) |
| Weeks tracked | 25 |
| Tracking since | Jan 7, 2026 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN ER 300 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $1.0468 per EA (NDC 50228052390), effective Jun 24, 2026.
How has the price of GABAPENTIN ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for GABAPENTIN ER 300 MG TABLET has declined 28.8%. It has been tracked across 25 weekly CMS publications since Jan 7, 2026.
What are the highest and lowest recorded NADAC prices for GABAPENTIN ER 300 MG TABLET?
Since Jan 7, 2026, the NADAC for GABAPENTIN ER 300 MG TABLET has ranged from a low of $1.0468 (Jun 17, 2026) to a high of $1.4921 (Feb 11, 2026), with a median of $1.4743 per EA.
Are there cheaper alternatives to GABAPENTIN ER 300 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, GABAPENTIN 300 MG CAPSULE, is $0.0324 per EA — about 97% below GABAPENTIN ER 300 MG TABLET.
Who manufactures GABAPENTIN ER 300 MG TABLET?
GABAPENTIN ER 300 MG TABLET (NDC 50228052390) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification